Pharmacology Biochemistry and Behavior

期刊简介：Pharmacology Biochemistry & Behavior publishes original reports in the areas of pharmacology and biochemistry in which the primary emphasis and theoretical context are behavioral. Contributions may involve clinical, preclinical, or basic research. Purely biochemical or toxicology studies will not be published. Papers describing the behavioral effects of novel drugs in models of psychiatric, neurological and cognitive disorders, and central pain must include a positive control unless the paper is on a disease where such a drug is not available yet. Papers focusing on physiological processes (e.g., peripheral pain mechanisms, body temperature regulation, seizure activity) are not accepted as we would like to retain the focus of Pharmacology Biochemistry & Behavior on behavior and its interaction with the biochemistry and neurochemistry of the central nervous system. Papers describing the effects of plant materials are generally not considered, unless the active ingredients are studied, the extraction method is well described, the doses tested are known, and clear and definite experimental evidence on the mechanism of action of the active ingredients is provided.

【译文】《药理学、生化与行为》发表关于药理学和生化领域的研究报告，主要强调行为方面的理论和实践。贡献可能涉及临床、临床前或基础研究。纯生化或毒理学研究将不予发表。描述新型药物在精神、神经和认知障碍模型以及中枢疼痛模型中的行为效应的论文必须包括阳性对照，除非论文是关于尚无此类药物可用的疾病。专注于生理过程（例如，外周疼痛机制、体温调节、癫痫活动）的论文不予接受，因为我们希望保持《药理学、生化与行为》杂志在行为及其与中枢神经系统生化与神经生化相互作用方面的重点。描述植物材料效应的论文通常不予考虑，除非活性成分被研究，提取方法描述良好，已知测试剂量，并提供了活性成分作用机制的明确和确凿实验证据。